About 1 result found for searched term "Tifcemalimab" (0.158 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M25331 | Tifcemalimab | Others |
| JS004 | ||
| Tifcemalimab (JS004) is a humanized anti-BTLA (B and T lymphocyte attenuation factor) monoclonal antibody. Tifcemalimab blocks the interaction of HVEM-BTLA by binding to BTLA, and thus blocks the inhibitory signaling pathway mediated by BTLA. Tifcemalimab can be used in research of cancer. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
